2013 EU Critical Utilities Conference2013 EU Critical Utilities Conference2013 EU Critical Utilities Conference
Share:          

Event Highlights

Plant Tours - 12 March 2013 (PM)

In the afternoon of day one, delegates will have the opportunity to visit one of three state-of-the art sites to see in action the concepts presented during the different sessions.
(Places are limited for each site and will be allocated on a first-come, first-served basis)

Take Back to Your Job:

  • View world-class facilities
  • Share best practice and knowledge
  • Network with colleagues
  • Benchmark your own operations

Novo Nordisk A/S

Gentofte, Denmark

www.novonordisk.com

Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.

H. Lundbeck A/S

Copenhagen Valby, Denmark

www.lundbeck.com

H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders.
Lundbeck aims to continue to develop new and innovative pharmaceuticals to help people who suffer from CNS (central nervous system) diseases. The ISPE plant tour will include an overview of Lundbeck, our innovative pharmaceutical products and our production.

Statens Serum Institut (SSI)

Copenhagen, Denmark

www.ssi.dk

Statens Serum Institut (SSI) is responsible for research-based health surveillance, rational use of IT in the Danish healthcare system and prevention and control of infectious diseases, biological threats and congenital disorders.
SSI is a public enterprise under the Danish Ministry of Health. For more than 100 years SSI’s main task has been to secure the preparedness towards infectious diseases and congenital disorders. The tasks have been expanded, and today, SSI is an international research, production and service enterprise. SSI aims to ensure advanced control of infectious diseases, including new infections and biological threats. The Institute also strives to be a highly regarded and recognised national and international research, production and service enterprise.
 

Agenda - Tuesday, 12 March PM

Coaches for the plant venues will depart from the Congress venue at 15h00, and are expected to return at 18h00.
 

Thank you to our Top Tier Sponsors

  • Pinnacle Sponsor
  • Pinnacle Sponsor
  • Pinnacle Sponsor

Follow ISPE

ISPE Twitter Page ISPE Facebook Page ISPE LinkedIn Page